USPTO serial 87943588
NOVALIQ
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 21, 2019
- Examiner
- MARTIN,JENNIFER MCGARRY
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights. Track next renewal deadlines in TSDR and WIPO records.
Need help with NOVALIQ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Heidelberg, DE
Heidelberg, DE
Heidelberg, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Pina M. Campagna
Pina M. Campagna Carter, Deluca, & Farrell, LLP576 Broad Hollow RoadMelville, NY 11747United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ (based on 44(e)) Chemical and biochemical preparations used in industry, namely, semifluorinated alkanes as bases for manufacturing medical aids, and for manufacturing pharmaceutical or medical preparations; chemical preparations used in industry, namely, chemical additives for use in the manufacture of pharmaceuticals ] | SECTION 8 - CANCELLED | — |
| 005 | [ (based on 44(e)) Biological, chemical and biochemical preparations for pharmaceutical or medical purposes, namely, ophthalmologic and dermatologic preparations; biological, chemical and biochemical diagnostic preparations for medical use; pharmaceutical preparations, exclusive of medicaments and medicines, namely, for treating skin diseases and disorders; pharmaceutical preparations, exclusive of medicaments and medicines, namely, for treating eye diseases and disorders ] | SECTION 8 - CANCELLED | — |
| 041 | (based on 44(e) with claim of priority under 44(d)) Publishing and issuing scientific papers in relation to medical technology; publishing of electronic publications | ACTIVE | — |
| 042 | (based on 44(e) with claim of priority under 44(d)) Pharmaceutical product evaluation, pharmaceutical research services, pharmaceutical product development, conducting early evaluations in the field of new pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Novaliq GmbH
- Other trademarks owned by Novaliq GmbH
- Other trademarks owned by Novaliq GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named NOVALIQ
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 31, 2025 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Dec 31, 2025 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Dec 31, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 26, 2025 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| May 21, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jul 16, 2019 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Jul 11, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 18, 2019 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| May 21, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 5, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 5, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 13, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 28, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 31, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 31, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 31, 2018 | ALIE | ASSIGNED TO LIE | — |
| Dec 22, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 22, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 19, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 19, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 9, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 27, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 27, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 27, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 23, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 7, 2018 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Jun 7, 2018 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jun 7, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 4, 2018 | NWAP | NEW APPLICATION ENTERED | — |